Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 275 of 885 entries
View as:

A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT02293395 Org: User:
Start: 04/20/15 End: 10/14/16 Due: 10/14/17

A Prospective Patient Registry of Patients Exposed to Bedaquiline

Phase: N/A Priority: Normal
NCT ID: NCT02274389 Org: User:
Start: 12/24/13 End: 11/20/18 Due: 11/20/19

A Study of JNJ-38518168 in Symptomatic Adult Participants With Uncontrolled, Persistent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01823016 Org: User:
Start: 09/30/13 End: 07/31/15 Due: 07/31/16

A Safety and Efficacy Study of JNJ-42165279 in Participants With Social Anxiety Disorder

Phase: N/A Priority: Normal
NCT ID: NCT02432703 Org: User:
Start: 06/11/15 End: 08/09/18 Due: 08/09/19

A Study of Paliperidone Palmitate 6-Month Formulation

Phase: N/A Priority: Normal
NCT ID: NCT04072575 Org: User:
Start: 09/19/19 End: 05/03/22 Due: 05/03/23

A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression

Phase: N/A Priority: Normal
NCT ID: NCT02417064 Org: User:
Start: 08/10/15 End: 02/20/18 Due: 02/20/19

Addition of Daratumumab to Combination of Bortezomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT02136134 Org: User:
Start: 08/15/14 End: 01/12/24 Due: 01/12/25

A Study of Paliperidone Palmitate 6-Month Formulation

Phase: N/A Priority: Normal
NCT ID: NCT03345342 Org: User:
Start: 11/20/17 End: 05/08/20 Due: 05/08/21

A Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNFα Naive Participants With Active Radiographic Axial Spondyloarthritis

Phase: N/A Priority: Normal
NCT ID: NCT02437162 Org: User:
Start: 09/03/15 End: 09/06/17 Due: 09/06/18

A Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNF(Alpha) Refractory Participants With Active Radiographic Axial Spondyloarthritis

Phase: N/A Priority: Normal
NCT ID: NCT02438787 Org: User:
Start: 07/31/15 End: 08/31/17 Due: 08/31/18

A Study to Evaluate Subcutaneous Daratumumab in Combination With Standard Multiple Myeloma Treatment Regimens

Phase: N/A Priority: Normal
NCT ID: NCT03412565 Org: User:
Start: 04/26/18 End: 04/18/24 Due: 04/18/25

54135419SUI3002: A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide

Phase: N/A Priority: Normal
NCT ID: NCT03097133 Org: User:
Start: 06/15/17 End: 04/11/19 Due: 04/11/20

A Study of Lazertinib in Participants With Epidermal Growth Factor Receptor (EGFR) Mutation Positive Advanced Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT04075396 Org: User:
Start: 10/16/19 End: 11/14/22 Due: 11/14/23

A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS)

Phase: N/A Priority: Normal
NCT ID: NCT04968912 Org: User:
Start: 09/21/21 End: 11/30/23 Due: 11/30/24

A Study to Evaluate the Efficacy and Safety of JNJ-42847922 as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy

Phase: N/A Priority: Normal
NCT ID: NCT03227224 Org: User:
Start: 08/16/17 End: 01/19/19 Due: 01/19/20

An Extension Study to Evaluate the Long-Term Safety and Tolerability of JNJ-54861911 in Participants in the Early Alzheimer's Disease Spectrum

Phase: N/A Priority: Normal
NCT ID: NCT02406027 Org: User:
Start: 07/02/15 End: 06/28/18 Due: 06/28/19

A Study to Evaluate the Efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant in Elderly Participants With Treatment-resistant Depression

Phase: N/A Priority: Normal
NCT ID: NCT02422186 Org: User:
Start: 08/20/15 End: 08/10/17 Due: 08/10/18

A Study to Investigate the Safety of the Drugs Topiramate and Levetiracetam in Treating Children Recently Diagnosed With Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT02201251 Org: User:
Start: 10/06/14 End: 04/30/20 Due: 04/30/21

A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide or in Combination With Pomalidomide for Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT06768489 Org: User:
Start: 12/04/24 End: 03/31/28 Due: 03/31/29

A Study to Assess Effects of Clarithromycin on Pharmacokinetics of JNJ-54861911 in Healthy Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT02197884 Org: User:
Start: 07/31/14 End: 09/30/14 Due: 09/30/15

A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT04673357 Org: User:
Start: 04/06/21 End: 03/03/25 Due: 03/03/26

A Study of Talquetamab With Other Anticancer Therapies in Participants With Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT05050097 Org: User:
Start: 09/22/21 End: 04/07/27 Due: 04/07/28

A Study of JNJ-64281802 in Participants With Confirmed Dengue Fever

Phase: N/A Priority: Normal
NCT ID: NCT04906980 Org: User:
Start: 01/24/22 End: 03/21/23 Due: 03/21/24

An Expanded Access Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer Who Have Completed Clinical Study COU-AA-001

Phase: N/A Priority: Normal
NCT ID: NCT01664728 Org: User:
Start: 04/30/07 End: 09/30/12 Due: 09/30/13

A Study to Determine the Absorption, Metabolism, and Routes of Excretion of (14C) Radiolabeled Ibrutinib in Healthy Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT01674322 Org: User:
Start: 08/31/12 End: 09/30/12 Due: 09/30/13